NRX Pharmaceuticals Inc. (NRXP)
NASDAQ · Healthcare
NRX Pharmaceuticals Inc. EBITDA 2023–2025
NRX Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2024 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- NRX Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2026 was -4.7 M, a 21.66% increase year-over-year.
- NRX Pharmaceuticals Inc. ebitda for the twelve months ending March 31, 2026 was -15.5 M.
- NRX Pharmaceuticals Inc. annual ebitda for 2025 was -16.2 M, a 12.67% decrease from 2024.
- NRX Pharmaceuticals Inc. annual ebitda for 2024 was -18.5 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
NRX Pharmaceuticals Inc. EBITDA — FAQ
NRX Pharmaceuticals Inc. (NRXP) ebitda over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRXP's ebitda history?
The chart and table above show NRX Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.